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Recent evidence indicates that T11 (CD2), the sheep erythrocyte receptor, is a
functionally important molecule on the surface ofhuman T lymphocytes . CD2 binds
the cell surface ligand LFA-3 to mediate adhesion between T cells and other cell
types (1, 2) . In addition, CD2 is the target structure for an "alternative" pathway
of T cell activation . Thus, it has been shown that a combination of mAbs against
the T112 and T113 epitopes of CD2 induce IL-2 production and proliferation in
purified T cells andT cell clones (3) . This antigen-independent mode ofT cell trig-
gering appears to be functionally linked to that involving the CD3/TCR molecular
complex (4) .
According to the generally accepted view, CD2 is the earliestT cell lineage-specific
differentiation antigen to appear during thymic ontogeny, and precedes the expres-
sion ofCD3 (3, 5) . This differentiation model does not allow for any significant number
of cells with a CD2- /3' phenotype among immature (or mature) T cells . In line
with this prediction, cell surface expression ofCD3 has been found to depend on
the simultaneous expression ofCD2 on a number of -f-radiation-induced variants
of the Jurkat T cell clone (6) . In contrast to this proposal, however, we now report
that significant numbers ofCD2 - /3+ T cells are readily identified in specimens of
fetal human spleen and thymus . In addition, we have established IL-2-dependent
T cell clones from fetal human thymus that have maintained a CD2-
/3+ pheno-
type over several months of continuous culture . Therefore, we conclude that cell
surface expression ofthe CD2 differentiation antigen is not necessarily required for
the expression of the CD3 molecular complex on fetal human T lymphocytes .
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Cell Preparations.
￿
Frozen specimens of fetal human thymus and spleen obtained between
the 20th and 24th week of gestation were kindly provided by Dr. W. Heit, Department of
Hematology, University of Ulm . After thawing, cells were centrifuged on Ficoll-Hypaque
gradients to remove dead cells and debris. Mononuclear cells (MNC) were analyzed for the
presence of CD2' and CD3' T cells by simultaneous double-color cytofluorometry . 106
MNC were incubated for 30 min on ice with FITC-conjugated Leu5b (CD2) mAb and
phycoerythrin (PE)-conjugated Leu4 (CD3)mAb (both from Becton Dickinson &Co., Moun-
tain View, CA) . After washing with PBS/1 % FCS/0.1 % sodium azide, cells were analyzed
on a cell sorter (Epics V; Coulter Electronics, Hialeah, FL) on the basis of forward angle
light scatter and fluorescence intensity.
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Cell Cloning.
￿
Fetal spleen and thymus MNC were stained with FITC-Leu5b plus PE-
Leu4 mAbs as described above. CD2 - /CD3' and CD2'/CD3' T cell clones were established
by sorting stained MNC and delivering single cells of the respective phenotype into wells
of 96-well round-bottomed microtiter plates (Nunc, Roskilde, Denmark) with the aid of an
Epics V autoclone device . The cultures were supplemented with 105 irradiated peripheral
blood feeder cells per well, 1 ug/ml PHA-P (Wellcome Diagnostics, Burgwedel, FRG), and
50 U/ml human rIL-2 (Biogen, Geneva, Switzerland) . All cultures were incubated at 37'C
in a humidified atmosphere of5% C02 in air. Growth-positive wells were expanded in rIL-
2-containing medium ; established T cell clones were restimulated every third week with ir-
radiated EBV-transformed B cell lines and PHA-P, and were further propagated in rIL-
2-supplemented medium RPMI 1640 (Biochrom KG, Berlin, FRG) supplemented with 10%
heat-inactivated FCS .
Phenotypic Characterization of T Cell Clones .
￿
The following mAbs were used in direct or in-
direct staining procedures . Anti-CD2 : OKTlI (Ortho Pharmaceutical, Raritan, NJ), Leu5b
(Becton Dickinson & Co.), HuLy-ml (reference 7 ; Camon, Wiesbaden, FRG),MT 1100 (8) ;
anti-CD3 : Leu4 (Becton Dickinson & Co.) ; antiTCR-a/a heterodimer : BMA031 (9) ; anti-
CD4 : OKT4 (Ortho Pharmaceuticals) ; anti-CD8 : Leu2a (Becton Dickinson & Co.) . Roset-
ting ofT cell clones with sheep erythrocytes was performed as follows . 2 x 10 5 cloned T cells
were centrifuged with 0 .1 ml of a 10% suspension of neuraminidase-treated sheep erythro-
cytes (E ) . After incubation for 60 min on ice, the pellet was gently resuspended, and ro-
sette formation was visualized under an inverted microscope .
Results and Discussion
Identification of CD2- /3' T Cells in Fetal Tissue .
￿
We have used simultaneous
double-color cytofluorometry to study the expression ofCD2 and CD3 antigens on
the surface of fetal human spleen and thymus cells. To this end, MNC were stained
with FITC-conjugated Leu5b (CD2) and PE-conjugated Leu4 (CD3) mAbs and
analyzed on an EpicsV cell sorter. In addition to commonly observed phenotypes
ofCD2' /3' mature T cells and CD2' 3 - "stage I"T cells (5), varying yet significant
numbers of CD2 - /3' cells were detected in the spleen and/or thymus of all seven
fetal specimens tested . As reported in Table I, from 1 to 23 ,70 of fetal spleen MNC
and from 3 to 23°Io of fetal thymus MNC displayed the CD2 - /3' phenotype .
Whereas thymus MNC contained more CD2 - /3' cells than splenic MNC in five
of seven cases, the reverse was true for two other specimens (P712, P736) from the
24th week of gestation . A representative three-dimensional fluorescence intensity
plot ofP736 spleen MNC stained with FITC-Leu5b and PE-Leu4 is shown in Fig.
1 . A distinct peak of CD2- /3' cells is clearly present on they-axis .
Phenotypic Characterization of a CD2- /3' T Cell Clone.
￿
To verify the existence of
CD2 - /3' T cells at the clonal level, we have established IL-2-dependent clones with
the aid ofthe Epics V autoclone device . FetalMNC were stained with FITC-Leu5b
and PE-Leu4, and cell sorter gates were set to deposit single cells of either CD2-/3'
or CD2' /3' phenotype into wells of microtiter plates containing irradiated feeder
cells, PHA-P, and rIL-2 . Growing clones were expanded over 4 mo in rIL-2-sup-
plemented medium . The phenotypic characterization of two representative clones
(both derived from fetal thymus P712) is shown in Fig. 2 . Clone D637/2 is CD3',
CD4', CD8- , TCR-a/R - , and CD2 - as revealed by a panel of mAbs directed
against the T11 I epitope of CD2 . In contrast, clone D637/5, selected from a
CD2' /3' progenitor, displays the CD3', CD4', CD8 - , TCR-a/R- , CD2' pheno-
type . In line with the CD2 surface expression, clone D637/5 forms rosettes with sheep
erythrocytes, while clone D637/2 does not (Fig . 3) . Recently, we found that bothKABELITZ AND CONRADT
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TABLE I
Simultaneous Double-Color Analysis of Different Fetal Human Thymus andSpleen
Specimens with FITC-labeled Leu5b (CD2) and PE-labeled Leu4 (CD3) mAbs
1943
clones express theTCR 7 chain as shown by reactivity with the TirA mAb (10) .
In addition to clone D637/2, we have established seven clones from two fetal spleen
and one fetal thymus samples that have maintained a stable CD2-/CD3 + pheno-
type over 2-4 mo of continuous culture .
These data clearly demonstrate that significant numbers ofCD2-/CD3 + T cells
are present in fetal human spleen and thymus obtained between the 20th and 24th
week of gestation . It should be stressed that cryopreserved material was used through-
out this study to identify CD2-/CD3+ T cells . We cannot completely rule out the
possibility that particular cell subsetsare preferentially lost or preserved during storage
in liquid nitrogen . Therefore, further studies will be conducted to identify
CD2- /CD3' T cells on freshly obtained fetal material . Together with the fact that
phenotypically stable clones of CD2-/CD3' T cells can be established from fetal
FIGURE 1 . Three-dimensional fluorescence intensity
plot ofCD2 and CD3 expression . Fetal spleen MNC
(sample P736) were stained with FITC-Leu5b (CD2 ;
x-axis)and PE-Leu4 (CD3;y-axis) and analyzed on an
EpicsVcell sorter. A distinct peak ofCD2-/CD3* cells
is seen on they-axis . The distribution of CD2' and
CD3' cells was as follows : 19.6% CD2- /3', 19.5%
CD2'/3', 3.0% CD2'/3-, and 57 .9% CD2- /3- .
Sample
Week of
gestation Organ
Percentage of cells
CD2 - /3' CD2*/3'
with phenotype :
CD2`/3 - CD2- /3 -
P677 22 Spleen 1 .2 9.6 4.8 84 .4
Thymus 3.4 45.7 22.6 28 .3
P712 24 Spleen 23 .5 13 .1 2 .5 60 .9
Thymus 22 .7 29.8 7 .3 40 .2
P736 24 Spleen 19.6 19 .5 3 .0 57 .9
Thymus 8.6 46 .3 15 .3 29 .8
P756 20 Spleen 4 .3 11 .4 9.3 75.0
Thymus 11 .1 61 .0 10.6 17 .3
P797 22 Spleen 5 .1 5.2 2.9 86.8
Thymus 14 .0 28 .5 11 .0 46.5
P834 ND Spleen 4.3 5.0 4.0 86.7
Thymus 16 .8 38.6 4.4 40.2
P1295 20 Spleen 2.8 8.4 7.2 81.6
Thymus 12 .9 26.2 11.7 49 .11944
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FIGURE 2.
￿
Surface marker anal-
ysis of IL-2-dependent clones
derived from fetal thymus P712 .
Clone D637/2 was establish-
ed from CD2 - /3' (Leu5b-/
Leu4') progenitor, done D637/
5 from a CD2' /3' (Leu5b'/
Leu4') progenitor. Cloned
cells were stained with fluoro-
chrome-conjugatedmAbs (Leu-
5b-FITC, Leu4-PE, OKT4-
FITC, Leu2a-PE), or with
unconjugated mAbs (OKTll,
MT1100, HuLyMl) and FITC-
labeled F(ab')z goat anti-mouse
Ig as a second antibody, or
with biotin-conjugated mAb
BMA031 and PE-streptavidin
as a second reagent . All samples
were analyzed on an Epics V
cell sorter.
tissue, our results argue, however, against the view that cell surface expression of
CD2 is an absolute prerequisite for the expression of the CD3 molecular complex
(5, 6). This conclusion appears to be further supported by a recent study on CD2
mRNA expression during fetal murine thymus ontogeny, in which Owen et al . (11)
detected CD3 y chainmRNA in the absence ofCD2 mRNA in day 14 fetal thymo-
cytes . In addition, it has recently been found (12) that a significant fraction ofTCR-
y+ T cells from one adult individual expressed the CD2 -/CD3 + phenotype . The
available data thus suggest that a sizable fraction ofCD3 +/TCRy; T cells do not
coexpress theCD2differentiation antigen . It isunknown at present, however, whether
the CD2-/CD3+ phenotype is restricted to TCR y chain-expressing T cells or
whether it is also present among "conventional" TCRa/p mature T cells .
In conclusion, we have identified a novel phenotype ofCD2 -/3' humanT cells .
We anticipate that paired clones ofCD2 - /3+ and CD2`/3' T cells as established
in this study will be helpful in further elucidating the role of the CD2 molecule inKABELITZ AND CONRADT
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FIGURE 3 .
￿
Sheep erythrocyte
rosette formation ofcloned fetal
T cells . Clone D637/2 (a, left)
and clone D637/5 (b, right) were
incubated with neuraminidase-
treated sheeperythrocytes as de-
scribed under Materials and
Methods .
T cell physiology (1316) . In addition, further studies will address the question of
whether CD2- /3+ cells are also detected among mature peripheral blood T lym-
phocytes .
Summary
From 1 to 23% of fetal human spleen or thymus cells (from the 20th to 24th week
of gestation) were found to display a previously unrecognized CD2 -/CD3 + pheno-
type. IL-2-dependent, long-term clones of CD2 - /3+ T cells did not react with a
panel of anti-CD2 mAbs and did not form rosettes with sheep erythrocytes. These
results show that (a) significant numbers of CD2- /3 + T cells are present in fetal
human spleen and/or thymus ; and (b) in contrast to the widely accepted view, ex-
pression ofCD2 is not a prerequisite for the expression of the CD3 molecular com-
plex on human T cells .
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